To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Clinical trial NCT06500494 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06500494
- Sponsor
- Pierre Fabre Medicament
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-10
- Primary completion
- 2028-09-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.